A Phase I, Open Label, Multicenter Trial of Oral Azacitidine (CC-486) Plus R-CHOP in Patients with High-Risk, Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma

被引：0
|
作者：
Martin, Peter
Bartlett, Nancy L.
Rivera, Ildefonso Ismael Rodriguez
Revuelta, Maria
Chavez, Julio C.
Reagan, John L.
Smith, Sonali M.
LaCasce, Ann S.
Zhang, Lei
Zhai, Merry
Wu, Chengqing
Leonard, John P.
Cerchietti, Leandro
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
192
引用
收藏
页数：2
相关论文
共 50 条
  • [41] R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial
    Hara, Takeshi
    Yoshikawa, Takeshi
    Goto, Hideko
    Sawada, Michio
    Yamada, Toshiki
    Fukuno, Kenji
    Kasahara, Senji
    Shibata, Yuhei
    Matsumoto, Takuro
    Mabuchi, Ryoko
    Nakamura, Nobuhiko
    Nakamura, Hiroshi
    Ninomiya, Soranobu
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Nannya, Yasuhito
    Katsumura, Naoki
    Takahashi, Takeshi
    Kito, Yusuke
    Takami, Tsuyoshi
    Miyazaki, Tatsuhiko
    Takeuchi, Tamotsu
    Shimizu, Masahito
    Tsurumi, Hisashi
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (04) : 638 - 644
  • [42] Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
    Vitolo, Umberto
    Chiappella, Annalisa
    Franceschetti, Silvia
    Carella, Angelo Michele
    Baldi, Ileana
    Inghirami, Giorgio
    Spina, Michele
    Pavone, Vincenzo
    Ladetto, Marco
    Liberati, Anna Marina
    Molinari, Anna Lia
    Zinzani, Pierluigi
    Salvi, Flavia
    Fattori, Pier Paolo
    Zaccaria, Alfonso
    Dreyling, Martin
    Botto, Barbara
    Castellino, Alessia
    Congiu, Angela
    Gaudiano, Marcello
    Zanni, Manuela
    Ciccone, Giovannino
    Gaidano, Gianluca
    Rossi, Giuseppe
    LANCET ONCOLOGY, 2014, 15 (07): : 730 - 737
  • [43] First-Line Treatment With Subcutaneous Epcoritamab plus R-CHOP in Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Phase 1/2 Data Update
    Falchi, Lorenzo
    Offner, Fritz
    Belada, David
    Brody, Joshua
    Linton, Kim M.
    Karimi, Yasmin
    Cordoba, Raul
    Snauwaert, Sylvia
    Abbas, Aqeel
    Wang, Liwei
    Wu, Jun
    Elliott, Brian
    Clausen, Michael Roost
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S380 - S380
  • [44] Subcutaneous Epcoritamab With R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma, Including Double-Hit/Triple-Hit Lymphoma: Updated Results From EPCORE NHL-2
    Falchi, Lorenzo
    Clausen, Roost Michael
    Offner, Fritz
    de Vos, Sven
    Joshua, Brody D.
    Kim, Linton M.
    Snauwaert, Sylvia
    Cordoba, Raul
    Oki, Toshihiko
    Bykhovski, Irina
    Wang Liwei
    Rana, Ali
    Belada, David
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S50 - S50
  • [45] Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma
    Liu, Yan-Yan
    Leboeuf, Christophe
    Shi, Jing-Yi
    Li, Jun-Min
    Wang, Li
    Shen, Yang
    Garcia, Jose-Francisco
    Shen, Zhi-Xiang
    Chen, Zhu
    Janin, Anne
    Chen, Sai-Juan
    Zhao, Wei-Li
    BLOOD, 2007, 110 (01) : 339 - 344
  • [46] A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma
    Park, Steven I.
    Grover, Natalie S.
    Olajide, Oludamilola
    Asch, Adam S.
    Wall, James G.
    Richards, Kristy L.
    Sobol, Anna L.
    Deal, Allison M.
    Ivanova, Anastasia
    Foster, Matthew C.
    Muss, Hyman B.
    Shea, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 281 - 289
  • [47] Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lymphoma.: An update of the GELA study.
    Coiffier, B
    Fermé, C
    Hermine, O
    Haioun, C
    Baumelou, E
    Solal-Celigny, P
    Delmer, A
    Sebban, C
    Mounier, N
    Tertian, G
    Van Hoof, A
    Bosly, A
    BLOOD, 2001, 98 (11) : 725A - 725A
  • [48] A Phase II Study of Chidamide Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An Interim Analysis
    Xu, Pengpeng
    Zhang, Muchen
    Fang, Ying
    Wang, Li
    Cheng, Shu
    Zhao, Wei-li
    BLOOD, 2017, 130
  • [49] Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2
    Sehn, Laurie
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S440 - S440
  • [50] Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma: Phase 1/2 Update
    Lorenzo, Falchi
    Fritz, Offner
    David, Belada
    Joshua, Brody
    Linton, Kim M.
    Yasmin, Karimi
    Raul, Cordoba
    Sylvia, Snauwaert
    Aqeel, Abbas
    Liwei, Wang
    Jun, Wu
    Brian, Elliott
    Clausen, Michael R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S30 - S30
12345